Crescita Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Crescita Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 26% to $17,522,000. Profit margin reached -11%. Total operating expenses were $12,320,000.
Profit Margin
| 2014 | 830K | -14.60M | -1759.16% |
|---|---|---|---|
| 2015 | 857K | -15.44M | -1802.57% |
| 2016 | 3.50M | -14.94M | -426.6% |
| 2017 | 12.01M | -11.46M | -95.41% |
| 2018 | 16.62M | 2.39M | 14.41% |
| 2019 | 22.33M | 1.85M | 8.3% |
| 2020 | 15.64M | 37K | 0.24% |
| 2021 | 16.76M | -1.10M | -6.59% |
| 2022 | 23.52M | 862K | 3.66% |
| 2023 | 17.52M | -1.98M | -11.33% |
CTX.TO Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 17.52M | 23.52M | 16.76M | 15.64M | 22.33M | 16.62M | 12.01M | 3.50M | 857K | 830K |
Cost of revenue | 7.15M | 10.34M | 6.75M | 4.36M | 5.80M | 5.53M | 4.84M | 2.33M | 501K | 279K |
Gross profit | 10.36M | 13.18M | 10.01M | 11.27M | 16.53M | 11.08M | 7.16M | 1.16M | 356K | 551K |
Operating exp. | ||||||||||
Research and development | 699K | 609K | 634K | 1.10M | 1.37M | 1.06M | 1.11M | 2.01M | 9.06M | 7.47M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 12.32M | 12.65M | 10.73M | 9.71M | 11.56M | 11.12M | 13.35M | 15.73M | 15.71M | 14.02M |
Operating income | -1.95M | 732K | -529K | 2.51M | 3.97M | -37K | -6.57M | -14.56M | -15.36M | -13.47M |
Other income (expenses), net | 426K | -328K | -480K | -1.03M | -790K | 1.17M | -5.04M | -230K | -69K | -1.12M |
Income before tax | -1.53M | 404K | -1.00M | 520K | 3.18M | 649K | -11.25M | -14.79M | -15.44M | -14.60M |
Income tax expense | 456K | -458K | 96K | 483K | 1.32M | -1.77M | 651K | -2.09M | 40K | 52K |
Net income | -1.98M | 862K | -1.10M | 37K | 1.85M | 2.39M | -11.46M | -14.94M | -15.44M | -14.60M |
Earnings per share | ||||||||||
Basic EPS | -0.09 | 0.04 | -0.05 | 0.00 | 0.08 | 0.12 | -0.82 | -1.17 | -1.41 | -1.46 |
Diluted EPS | -0.09 | 0.04 | -0.05 | 0.00 | 0.08 | 0.12 | -0.82 | -1.17 | -1.35 | -1.39 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |